Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
COVID-19 vaccines
COVID-19 vaccines
Page 14 of 95
Commentary
A global effort to stop the spread of COVID-19 in Africa is underway–and it starts with health care workers
By
Adar Poonawalla
July 27, 2022
Tech
Facebook considers relaxing COVID-19 misinformation policies
By
Chris Morris
July 26, 2022
Health
China just approved its first domestic anti-COVID pill, Azvudine, and is ready to produce 6.8 billion pills a year at half the price of Pfizer’s Paxlovid
By
Grady McGregor
July 26, 2022
Health
Pfizer’s anti-COVID pill — used by Biden — is expected to rake in $23.2 billion, but confusion and weak demand could cause supply glut
By
Chloe Taylor
July 25, 2022
The Bill & Melinda Gates Foundation partly funded an Omicron variant study with a surprising conclusion about boosters
By
Christine Mui
July 21, 2022
Health
The U.S.’s woefully low COVID vaccination rate makes it Novavax’s most appealing market yet
By
Grady McGregor
July 20, 2022
Health
CDC endorses Novavax COVID shot for adults, adding to the number of vaccine options
By
Lauran Neergaard
and
The Associated Press
July 19, 2022
Commentary
New viral threats are moving fast. Here’s how we can move faster
By
Gavin Cloherty
July 18, 2022
A ‘breadth of protection’: Novavax’s newly approved COVID vaccine arms the U.S. with a new weapon against Omicron BA.5 subvariant
By
Grady McGregor
July 14, 2022
Commentary
COVID finally got me. Will it come for you?
By
Carolyn Barber
July 12, 2022
Health
An Omicron vaccine is coming. Should you wait for it—or get your next booster now amid BA.5’s surge?
By
Nicholas Gordon
July 12, 2022
Health
New Omicron subvariants are causing COVID rates to increase. These are the states where it’s most contagious right now
By
Andrew Marquardt
July 11, 2022
Commentary
Why remote work will win this fall
By
Gleb Tsipursky
July 11, 2022
Beijing imposes China’s first-ever vaccine mandate as the new, highly transmissible Omicron variant tests its COVID-zero defenses
By
Nicholas Gordon
July 7, 2022
Health
‘We will never be fully vaccinated against COVID’: Canadians may be required to get booster shot every 9 months
By
Sophie Mellor
July 5, 2022
Most Popular
Economy
‘Sell America’: Investors dump U.S. assets in fear of the end of Fed independence
By
Jim Edwards
Economy
Treasury spent $276 billion in interest on the national debt in the final three months of 2025, says the CBO—up $30...
By
Eleanor Pringle
Success
An exec at $62 billion giant Colgate says Gen Z workers, despite getting flak for being woke and lazy, are actually...
By
Emma Burleigh